Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 17, 2019 Off

Halo Labs to Expand Globally and Acquire Bophelo Bioscience

By BusinessWire

Cannabis Industry in Lesotho, Africa to Become Gateway to EU Cannabis Markets Not for Distribution to U.S. Newswire Servicers or…

June 17, 2019 Off

Halo Labs to Expand Globally and Acquire Bophelo Bioscience

By BusinessWire

Cannabis Industry in Lesotho, Africa to Become Gateway to EU Cannabis Markets Not for Distribution to U.S. Newswire Servicers or…

June 17, 2019 Off

Consolidated Container Company to Acquire Tri State Distribution, Inc., a Leading Producer and Distributor of Pharmaceutical Packaging

By BusinessWire

ATLANTA–(BUSINESS WIRE)–Consolidated Container Company (“CCC”) announced that it has acquired Tri State Distribution, Inc. (“Tri State”), a leading retail pharmaceutical…

June 17, 2019 Off

Global Biotechnology Instrumentation Market Analysis, Trends, and Forecasts to 2022 – Next-Generation Sequencing Technologies Drive the Momentum – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Biotechnology Instrumentation: Global Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. The report provides…

June 17, 2019 Off

Boehringer Ingelheim and OSE Immunotherapeutics Announce Dosing Of the First Patient in a Phase 1 Trial of SIRPα Antagonist Monoclonal Antibody, BI 765063, in Patients with Advanced Solid Tumors

By BusinessWire

First-in-class checkpoint inhibitor BI 765063 licensed to and being developed under a collaboration agreement between Boehringer Ingelheim and OSE Immunotherapeutics…

June 17, 2019 Off

Boehringer Ingelheim and OSE Immunotherapeutics Announce Dosing Of the First Patient in a Phase 1 Trial of SIRPα Antagonist Monoclonal Antibody, BI 765063, in Patients with Advanced Solid Tumors

By BusinessWire

First-in-class checkpoint inhibitor BI 765063 licensed to and being developed under a collaboration agreement between Boehringer Ingelheim and OSE Immunotherapeutics…

June 17, 2019 Off

VenatoRx Pharmaceuticals to Present at ASM Microbe 2019

By BusinessWire

MALVERN, Pa.–(BUSINESS WIRE)–#ASMMicrobe2019—VenatoRx Pharmaceuticals will present ten posters featuring its two development-stage products, cefepime/VNRX-5133 and ceftibuten/VNRX-7145, at ASM Microbe 2019…

June 17, 2019 Off

Shionogi to Present Cefiderocol and COT-143 Data at American Society for Microbiology Microbe 2019 Meeting

By BusinessWire

OSAKA, Japan & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced there will be one oral presentation…

June 17, 2019 Off

Shionogi to Present Cefiderocol and COT-143 Data at American Society for Microbiology Microbe 2019 Meeting

By BusinessWire

OSAKA, Japan & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced there will be one oral presentation…

June 17, 2019 Off

Shionogi to Present Cefiderocol and COT-143 Data at American Society for Microbiology Microbe 2019 Meeting

By BusinessWire

OSAKA, Japan & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced there will be one oral presentation…

Posts pagination

Previous 1 … 3,075 3,076 3,077 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine